Okada S, Okazaki N, Nose H, Aoki K, Kawano N, Yamamoto J, Shimada K, Takayama T, Kosuge T, Yamasaki S
Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
Hepatogastroenterology. 1993 Aug;40(4):311-5.
The tumor volume doubling time of 27 recurrent hepatocellular carcinoma nodules measuring < or = 2.0 cm in diameter discovered after hepatectomy in 19 patients was analyzed by ultrasonography for 31 to 331 days. The tumor volume doubling time ranged from 39 to 420 days before specific treatment, with a mean of 112 days and a median of 80 days. It correlated with age and intrahepatic site of recurrence, which was sometimes the same lobe as that of the prior hepatocellular carcinoma, sometimes not. The tumor volume doubling time also tended to correlate with hepatitis C antibody status and initial tumor diameter. The tumor volume doubling time was, however, independent of sex, hepatitis B surface antigen status, number of recurrent tumors, initial serum alpha-fetoprotein level, interval between hepatectomy and recurrence detection, and associated liver disease. On the basis of the shortest tumor volume doubling time of the recurrent hepatocellular carcinoma nodules, we recommend that US and/or CT be performed at least every four months to screen for small recurrent carcinomas in postoperative patients.
对19例肝切除术后发现的27个直径≤2.0 cm的复发性肝细胞癌结节进行超声检查分析,其肿瘤体积倍增时间为31至331天。在进行特异性治疗前,肿瘤体积倍增时间为39至420天,平均为112天,中位数为80天。它与年龄和肝内复发部位相关,复发部位有时与先前肝细胞癌在同一肝叶,有时则不同。肿瘤体积倍增时间也倾向于与丙型肝炎抗体状态和初始肿瘤直径相关。然而,肿瘤体积倍增时间与性别、乙型肝炎表面抗原状态、复发性肿瘤数量、初始血清甲胎蛋白水平、肝切除与复发检测之间的间隔时间以及相关肝病无关。基于复发性肝细胞癌结节最短的肿瘤体积倍增时间,我们建议术后患者至少每四个月进行一次超声和/或CT检查,以筛查小的复发性癌。